Bruce Montgomery, M.D.
Scientific Advisory Committee
CEO, Avalyn Pharma
Dr. Montgomery is the CEO Avalyn Pharma and has 30 years of pharmaceutical company experience in research, drug development, operations and financing. He has raised over $370 million in venture or public financings. He has authored 26 US Patents and more than 45 peer reviewed publications.
Dr. Montgomery has been instrumental for three complete drug approvals, aerosolized pentamidine, tobramycin solution for inhalation, aztreonam lysine for inhalation (the only three FDA approved inhaled antimicrobials); from invention to advisory board presentations. From 1985 to 1989, Dr Montgomery was co inventor, and then led the effort to obtain FDA approval of aerosolized pentamidine, the second AIDS drug approved by the FDA.
While at Genentech between 1989-1993, he started multiple other programs that have led to three other FDA approvals including Pulmozyme, Xolair and Raptiva. In 1998 the Commissioner of the FDA recognized Dr. Montgomery with special citation for leadership in the development and approval of tobramycin solution for inhalation. For this work, Dr. Montgomery also received the Inventor of the Year award from the University of Washington in 2009. In 2010, Dr. Montgomery received a scientific achievement award from the Cystic Fibrosis Foundation for his work on three CF drugs that have extended the average life span by over a decade. In 2011, Dr. Montgomery received a career achievement award from ISAM (International Society for Aerosols in Medicine). In 2011 he received the Timeless Award from the University of Washington college of arts and sciences, honoring the top 150 living graduates as part of the college's sesquicentennial. In 2015, he was elected to the Washington State Academy of Sciences. He has served as a board member for multiple companies and was a trustee of the Washington State Life Sciences Discovery Fund for a decade.
Dr. Montgomery received his Bachelor of Science in Chemistry in 1975 (Magna cum Laude, Outstanding Chemistry Major (Merck Award)), and Doctorate of Medicine in 1979 (Alpha Omega Alpha Honor Medical Society) from the University of Washington, Seattle. Dr. Montgomery is a board certified internist and pulmonologist and 30 year member of the ATS.
Page last updated: February 2, 2021
A Breath of Fresh Air in Your Inbox
Want updates on the latest lung health news, including COVID-19, research, inspiring stories and health information?
Join the 700,000+ people getting our email updates!
Thank you! You will now receive email updates from the American Lung Association.